Physician
Infectious Disease
Dr. Bruce L. Innis, MD
Bruce Innis is an expert in the field of Infectious Disease. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine Bruce L. Innis, MD is a published physician. He published 100 publications, including: 'Phylogenetic analysis of hepatitis E virus isolates from Egypt.'
Publications
- Evidence update: GlaxoSmithKline's inactivated quadrivalent influenza vaccines.
- Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.
- An Adjuvanted, Tetravalent Dengue Virus-Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesu...
- Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.
- Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.
- Retraction of the Letter: "Comment on 'CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy' ".
- Evaluation of Dengue Virus strains for human challenge studies.
- Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults age...
- Vaccine for prevention of mild and moderate-to-severe influenza in children.
- A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
- Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.
- A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults.
- Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants.
- Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate.
- Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: A randomized study in US adults.
- A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children.
- Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.
- Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults.
- Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.
- Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.
- Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.
- Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries.
- Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries.
- Safety and efficacy of a recombinant hepatitis E vaccine.
- Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
- Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal.
- Rapid licensure of a new, inactivated influenza vaccine in the United States.
- Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.
- Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.
- Serotype-specific T(H)1 responses in recipients of two doses of candidate live-attenuated dengue virus vaccines.
- Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.
- Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.
- Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
- Rapid detection of adenovirus in throat swab specimens by PCR during respiratory disease outbreaks among military recruits.
- Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.
- Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.
- Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M.
- Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay.
- Identification of a novel hepatitis E virus in Nigeria.
- Hemolytic anemia after tetracycline therapy.
- Falciparum malaria modulates viremia in chronic hepatitis B virus infection.
- Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a conc...
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
- A short report on highlights of world-wide development of RIX4414: a Latin American experience.
- Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.
- IgM capture ELISA for detection of IgM antibodies to dengue virus: comparison of 2 formats using hemagglutinins and cell culture derived antigens.
- A short report on clinical evaluation of RIX4414: highlights of world-wide development.
- Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household.
- Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
- Hepatitis E antibody kinetics in Nepalese patients.
- Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951.
- An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
- Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
- Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.
- Clinical and immunological risk factors for severe disease in Japanese encephalitis.
- Mechanisms of hemorrhage in dengue without circulatory collapse.
- Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults.
- A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
- A novel method for the preparation of large cDNA fragments from dengue-3 RNA genome by long RT-PCR amplification.
- Highly conserved nucleotide sequence and its deduced amino acids of the 5''-noncoding region and the capsid protein of a Bangkok isolate dengue-3 virus.
- Distribution of dengue and Japanese encephalitis among children in rural and suburban Thai villages.
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.
- Limited potential for transmission of live dengue virus vaccine candidates by Aedes aegypti and Aedes albopictus.
- An outbreak of hepatitis E in Northern Namibia, 1983.
- Hepatitis E virus DNA vaccine elicits immunologic memory in mice.
- Hepatitis B virus infection in Thai children.
- Hepatitis E vaccine for travelers?
- B cells are the principal circulating mononuclear cells infected by dengue virus.
- Detection of adenoviruses (AdV) in culture-negative environmental samples by PCR during an AdV-associated respiratory disease outbreak.
- Molecular characterization of a hepatitis E virus isolate from Namibia.
- Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus.
- Short report: phylogenetically distinct hepatitis E viruses in Pakistan.
- Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice.
- Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation.
- Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.
- Protection against Japanese encephalitis by inactivated vaccines.
- An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.
- Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus.
- Virus-like particles in the liver of a patient with fulminant hepatitis and antibody to hepatitis E virus.
- Murine typhus identified as a major cause of febrile illness in a camp for displaced Khmers in Thailand.
- Human immune responses to dengue viruses.
- Sensitivity and specificity of a universal primer set for the rapid diagnosis of dengue virus infections by polymerase chain reaction and nucleic acid hybridization.
- Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in...
- Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection.
- The declining transmission of hepatitis A in Thailand.
- Correlation of E protein binding with cell susceptibility to dengue 4 virus infection.
- Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion.
- Causes of death and unintentional injury among schoolchildren in Thailand.
- Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
- Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinit...
- The socioeconomic impact of hepatitis E in Nepal.
- Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
- Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus.
- An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
- Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity.
- Phylogenetic analysis of hepatitis E virus isolates from Egypt.
- Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 3 virus, Bangkok genotype.
- Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate.
Schools
Yale University
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Thomas C. Heineman, MD |
|
|
Dr. John F. Riefler III, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald Kaye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred J. Saah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel N. Maslow, MD
This Doctor is OpenDoctor Recommended.
|